• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于多发性内分泌肿瘤 1 型原发性甲状旁腺功能亢进症,行次全甲状旁腺切除术与全甲状旁腺切除术的疗效比较:系统评价和荟萃分析。

Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.

机构信息

Digestive and Endocrine Surgery Department, Magellan Center, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France.

Endocrinology Department, INSERM Unit 1215, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France.

出版信息

World J Surg. 2022 Nov;46(11):2666-2675. doi: 10.1007/s00268-022-06633-7. Epub 2022 Jun 29.

DOI:10.1007/s00268-022-06633-7
PMID:35767091
Abstract

BACKGROUND

Multiple endocrine neoplasia type 1 (MEN1)-associated primary hyperparathyroidism (pHPT) is classically associated with an asymmetric and asynchronous parathyroid involvement. Subtotal parathyroidectomy (STP), which is currently the recommended surgical treatment, carries a high risk of permanent hypoparathyroidism. The results of less than subtotal parathyroidectomy (LSTP) are conflicting, and its place in this setting is still a matter of debate. The aim of this study was to identify the place of LSTP in the surgical management of patients with MEN-associated pHPT.

METHODS

A systematic literature review was conducted in accordance with PRISMA and MOOSE guidelines, for studies comparing STP and LSTP for MEN1-associated pHPT. The results of the two techniques, regarding permanent hypoparathyroidism, persistent hyperparathyroidism and recurrent hyperparathyroidism were computed using pairwise random-effect meta-analysis.

RESULTS

Twenty-five studies comparing STP and LSTP qualified for inclusion in the quantitative synthesis. In total, 947 patients with MEN1-associated pHPT were allocated to STP (n = 569) or LSTP (n = 378). LSTP reduces the risk of permanent hypoparathyroidism [odds ratio (OR) 0.29, confidence interval (CI) 95% 0.17-0.49)], but exposes to higher rates of persistent hyperparathyroidism [OR 4.60, 95% CI 2.66-7.97]. Rates of recurrent hyperparathyroidism were not significantly different between the two groups [OR 1.26, CI 95% 0.83-1.91].

CONCLUSIONS

LSTP should not be abandoned and should be considered as a suitable surgical option for selected patients with MEN1-associated pHPT. The increased risk of persistent hyperparathyroidism could improve with the emergence of more efficient preoperative localization imaging techniques and a more adequate patients selection.

摘要

背景

多发性内分泌腺瘤病 1 型(MEN1)相关的原发性甲状旁腺功能亢进症(pHPT)通常与甲状旁腺的不对称和不同步受累有关。次全甲状旁腺切除术(STP)是目前推荐的手术治疗方法,但有发生永久性甲状旁腺功能减退的高风险。少于次全甲状旁腺切除术(LSTP)的结果存在争议,其在这种情况下的地位仍存在争议。本研究旨在确定 LSTP 在 MEN 相关 pHPT 患者的手术治疗中的地位。

方法

根据 PRISMA 和 MOOSE 指南进行系统文献回顾,以比较 STP 和 LSTP 治疗 MEN1 相关 pHPT 的研究。使用配对随机效应荟萃分析计算两种技术在永久性甲状旁腺功能减退、持续性甲状旁腺功能亢进和复发性甲状旁腺功能亢进方面的结果。

结果

25 项比较 STP 和 LSTP 的研究符合纳入定量综合的标准。共有 947 名 MEN1 相关 pHPT 患者被分配至 STP(n=569)或 LSTP(n=378)组。LSTP 降低永久性甲状旁腺功能减退的风险[比值比(OR)0.29,95%置信区间(CI)0.17-0.49],但增加持续性甲状旁腺功能亢进的风险[OR 4.60,95%CI 2.66-7.97]。两组间复发性甲状旁腺功能亢进的发生率无显著差异[OR 1.26,95%CI 0.83-1.91]。

结论

不应放弃 LSTP,应将其视为 MEN1 相关 pHPT 患者的一种合适的手术选择。随着更有效的术前定位成像技术和更充分的患者选择的出现,持续性甲状旁腺功能亢进的风险可能会降低。

相似文献

1
Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.对于多发性内分泌肿瘤 1 型原发性甲状旁腺功能亢进症,行次全甲状旁腺切除术与全甲状旁腺切除术的疗效比较:系统评价和荟萃分析。
World J Surg. 2022 Nov;46(11):2666-2675. doi: 10.1007/s00268-022-06633-7. Epub 2022 Jun 29.
2
The role of Rapid Intraoperative Parathyroid Hormone (ioPTH) assay in determining outcome of parathyroidectomy in primary hyperparathyroidism: A systematic review and meta-analysis.甲状旁腺激素(ioPTH)快速检测在原发性甲状旁腺功能亢进症甲状旁腺切除术中的作用:系统评价和荟萃分析。
Int J Surg. 2021 Aug;92:106042. doi: 10.1016/j.ijsu.2021.106042. Epub 2021 Jul 30.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1.特定1型多发性内分泌腺瘤病患者原发性甲状旁腺功能亢进症的单侧清除术
World J Surg. 2016 Dec;40(12):2964-2969. doi: 10.1007/s00268-016-3624-9.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.预防产后出血的宫缩剂:一项网状Meta分析
Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2.

引用本文的文献

1
Potential benefits of intraoperative parathyroid autofluorescence imaging in a patient with multiple endocrine neoplasia type 1 and hyperparathyroidism - A case report.术中甲状旁腺自发荧光成像在1型多发性内分泌腺瘤病合并甲状旁腺功能亢进患者中的潜在益处——病例报告
Int J Surg Case Rep. 2025 Jan;126:110764. doi: 10.1016/j.ijscr.2024.110764. Epub 2024 Dec 24.
2
Bone mineral density over ten years after primary parathyroidectomy in multiple endocrine neoplasia type 1.1型多发性内分泌腺瘤病患者初次甲状旁腺切除术后十年的骨矿物质密度
JBMR Plus. 2024 Oct 22;8(12):ziae129. doi: 10.1093/jbmrpl/ziae129. eCollection 2024 Dec.
3

本文引用的文献

1
Clinical aspects of multiple endocrine neoplasia type 1.1 型多发性内分泌肿瘤的临床方面。
Nat Rev Endocrinol. 2021 Apr;17(4):207-224. doi: 10.1038/s41574-021-00468-3. Epub 2021 Feb 9.
2
Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: A meta-analysis.1 型多发性内分泌肿瘤综合征患者初始甲状旁腺切除术的最佳范围:一项荟萃分析。
Surgery. 2021 Feb;169(2):302-310. doi: 10.1016/j.surg.2020.08.021. Epub 2020 Sep 30.
3
F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism.
Familial states of primary hyperparathyroidism: an update.
家族性原发性甲状旁腺功能亢进症:最新进展。
J Endocrinol Invest. 2024 Sep;47(9):2157-2176. doi: 10.1007/s40618-024-02366-7. Epub 2024 Apr 18.
4
Surgical treatment of tertiary hyperparathyroidism: does one fit for all?三发性甲状旁腺功能亢进的手术治疗:一种方法适合所有人吗?
Front Endocrinol (Lausanne). 2023 Nov 2;14:1226917. doi: 10.3389/fendo.2023.1226917. eCollection 2023.
5
Persistent and Recurrent Primary Hyperparathyroidism: Etiological Factors and Pre-Operative Evaluation.持续性和复发性原发性甲状旁腺功能亢进:病因学因素及术前评估
Sisli Etfal Hastan Tip Bul. 2023 Mar 21;57(1):1-17. doi: 10.14744/SEMB.2023.39260. eCollection 2023.
6
Invited Commentary: Less than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.特邀评论:多发性内分泌腺瘤1型原发性甲状旁腺功能亢进症的次全甲状旁腺切除术:一项系统评价和荟萃分析
World J Surg. 2022 Nov;46(11):2676-2677. doi: 10.1007/s00268-022-06707-6. Epub 2022 Aug 30.
F-氟代胆碱 PET/CT 在 MEN1 伴发原发性甲状旁腺功能亢进症患者中的应用。
World J Surg. 2020 Nov;44(11):3761-3769. doi: 10.1007/s00268-020-05695-9. Epub 2020 Jul 17.
4
Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism.不同手术入路对 MEN1 相关甲状旁腺功能亢进症短期结局的影响。
Sci Rep. 2020 Jun 30;10(1):10634. doi: 10.1038/s41598-020-67424-5.
5
Surgery versus Imaging in Non-Localizing Primary Hyperparathyroidism: A Cost-Effectiveness Model.非定位性原发性甲状旁腺功能亢进症的手术与影像学检查:成本效益模型。
Laryngoscope. 2020 Dec;130(12):E963-E969. doi: 10.1002/lary.28566. Epub 2020 Feb 17.
6
MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes.西班牙登记处中与MEN1相关的原发性甲状旁腺功能亢进症:临床特征与手术结果
Endocr Connect. 2019 Oct;8(10):1416-1424. doi: 10.1530/EC-19-0321.
7
F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis.F-胆碱 PET/mpMRI 用于检测临床显著前列腺癌:第 2 部分。成本效益分析。
J Nucl Med. 2019 Dec;60(12):1705-1712. doi: 10.2967/jnumed.119.225771. Epub 2019 Jul 26.
8
Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study.慢性甲状旁腺功能减退症患者的长期并发症:一项横断面研究。
Eur J Endocrinol. 2019 Jan 1;180(1):71-78. doi: 10.1530/EJE-18-0580.
9
Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis.胆碱 PET 检测甲状旁腺功能亢进症中功能性亢进甲状旁腺的诊断性能:系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):751-765. doi: 10.1007/s00259-018-4123-z. Epub 2018 Aug 9.
10
Primary hyperparathyroidism associated with MEN 1: Experience in 71 cases.与多发性内分泌腺瘤病1型相关的原发性甲状旁腺功能亢进:71例经验
Cir Esp (Engl Ed). 2018 Dec;96(10):627-633. doi: 10.1016/j.ciresp.2018.06.014. Epub 2018 Jul 26.